Stopping GLP-1s and Addiction
Glucagon-like peptide-1 (GLP-1) receptor agonists have transformed the treatment of type 2 diabetes and obesity by improving blood glucose control, promoting weight loss, and reducing appetite. Medications such as Ozempic, Wegovy, and Mounjaro are also being studied for their potential effects on the brain’s reward system, with early research suggesting they may reduce cravings and … Read more